StockData
Verastem, Inc. logo

Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$7.41−0.29 (-3.77%)

Close on Nov 17, 2026Market cap $671.08MP/E –Yield –

Verastem total assets

Total assets on the balance sheet at the end of each period.

Verastem's total assets was $206.51M at Jun 30, 2026. For fiscal 2025 it was $246.44M, up 142.7% from the year before. Over ten years it grew 8.1% a year on average. The highest annual figure on record is $277.24M in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$246.44M+142.7%
FY2024Dec 31, 2024$101.54M-32.2%
FY2023Dec 31, 2023$149.72M+57.5%
FY2022Dec 31, 2022$95.05M-12.5%
FY2021Dec 31, 2021$108.66M-29.6%
FY2020Dec 31, 2020$154.35M+6.4%
FY2019Dec 31, 2019$145.05M-47.7%
FY2018Dec 31, 2018$277.24M+208.8%
FY2017Dec 31, 2017$89.79M+7.4%
FY2016Dec 31, 2016$83.63M-26.1%
FY2015Dec 31, 2015$113.09M+14.6%
FY2014Dec 31, 2014$98.65M-21.2%
FY2013Dec 31, 2013$125.26M+34.8%
FY2012Dec 31, 2012$92.92M+57.4%
FY2011Dec 31, 2011$59.04M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$206.51M+5.2%
Q1 FY2026Mar 31, 2026$227.81M+73.0%
Q4 FY2025Dec 31, 2025$246.44M+142.7%
Q3 FY2025Sep 30, 2025$176.85M+39.9%
Q2 FY2025Jun 30, 2025$196.26M+85.6%
Q1 FY2025Mar 31, 2025$131.70M-12.0%
Q4 FY2024Dec 31, 2024$101.54M-42.4%
Q3 FY2024Sep 30, 2024$126.38M-34.1%
Q1 FY2024Jun 30, 2024$105.75M-12.5%
Q4 FY2023Dec 31, 2023$149.72M+57.5%
Q3 FY2023Sep 30, 2023$176.15M+58.6%
Q2 FY2023Jun 30, 2023$191.76M+91.0%
Q1 FY2023Mar 31, 2023$120.88M+4.1%
Q4 FY2022Dec 31, 2022$95.05M-12.5%
Q3 FY2022Sep 30, 2022$111.10M-0.7%
Q2 FY2022Jun 30, 2022$100.41M-19.0%
Q1 FY2022Mar 31, 2022$116.15M-15.2%
Q4 FY2021Dec 31, 2021$108.66M-29.6%
Q3 FY2021Sep 30, 2021$111.88M-48.6%
Q2 FY2021Jun 30, 2021$123.89M-37.6%
Q1 FY2021Mar 31, 2021$136.90M-34.2%
Q4 FY2020Dec 31, 2020$154.35M+6.4%
Q3 FY2020Sep 30, 2020$217.77M+13.1%
Q2 FY2020Jun 30, 2020$198.53M-9.2%
Q1 FY2020Mar 31, 2020$208.15M-14.5%
Q4 FY2019Dec 31, 2019$145.05M-47.7%
Q3 FY2019Sep 30, 2019$192.60M+5.2%
Q2 FY2019Jun 30, 2019$218.54M+26.4%
Q1 FY2019Mar 31, 2019$243.37M+255.7%
Q4 FY2018Dec 31, 2018$277.24M+208.8%
Q3 FY2018Sep 30, 2018$183.16M+190.1%
Q2 FY2018Jun 30, 2018$172.92M+179.6%
Q1 FY2018Mar 31, 2018$68.41M-10.3%
Q4 FY2017Dec 31, 2017$89.79M+7.4%
Q3 FY2017Sep 30, 2017$63.14M-29.1%
Q2 FY2017Jun 30, 2017$61.84M-35.2%
Q1 FY2017Mar 31, 2017$76.25M–
Q4 FY2016Dec 31, 2016$83.63M–
Q3 FY2016Sep 30, 2016$89.04M–
Q2 FY2016Jun 30, 2016$95.42M–

More Verastem figures

See a number that looks wrong?